Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stratification for Efficacy of Adjuvant FOLFOX Plus Lenvatinib After Liver Transplantation for Hepatocellular Carcinoma in Recurrence Prevention

NCT06564103 is registered in ClinicalTrials.gov with Xiao Xu as lead sponsor.

NCT NCT06564103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06564103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stratification for Efficacy of Adjuvant FOLFOX Plus Lenvatinib After Liver Transplantation for Hepatocellular Carcinoma in Recurrence Prevention
Lead sponsor
Xiao Xu
Phase
Observational
Overall status
Completed
Start date
January 1, 2024
Completion date
August 5, 2024
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant folfox plus lenvatinib, liver transplantation, machine learning